Skip to content

Effect of BCI rehabilitation training combined with rTMS on upper limb and hand function recovery of ischemic stroke patient

Effect of BCI rehabilitation training combined with rTMS on upper limb and hand function recovery of ischemic stroke patient

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088161
Enrollment
Unknown
Registered
2024-08-13
Start date
2024-08-15
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

BCI group:BCI rehabilitation training based on visual motor induction + sham stimulation repetitive transcranial magnetic stimulation
rTMS group:Repeat transcranial magnetic stimulation + sham stimulation BCI training
Combined treatment group:BCI rehabilitation training based on visual motor induction + repetitive transcranial magnetic stimulation

Sponsors

The Second Affiliated Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. (1) A diagnosis that complies with the latest definition of stroke in the 21st century, which is confirmed by head CT or MRI imaging as unilateral cerebral ischemic stroke. (2) First onset, with a disease duration ranging from 2 weeks to 6 months, and an age range from 45 to 75 years. (3) The patient's condition is stable, their consciousness is clear, their vital signs are stable, and they can cooperate with treatment, examination and efficacy evaluation. (4) The Brunnstrom stages of the upper limbs and hands are at stage II-IV.

Exclusion criteria

Exclusion criteria: (1) Diseases related to motor function, such as rheumatoid arthritis, joint deformity, and spinal cord injury. (2) Severe upper limb pain (5 points or above based on the visual pain scale) affected patients' normal activities. (3) Serious cardiovascular, liver, kidney and other diseases, or patients with a history of seizures or epilepsy at high risk. (4) Patients with contraindications for repeated transcranial magnetic stimulation (such as pregnancy, cancer, blood clotting disorders, pacemakers or other electronic implants). (5) Use of drugs that may influence the electrical activity of the cortex (such as sedatives, antidepressants, etc.). (6) Patients currently participating in or about to participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer assessment upper extremity scale,FMA-UE;

Secondary

MeasureTime frame
Modified Barther Index, MBI;Montreal Cognitive Assessment (MoCA);Motor evoked potential;Central motor conduction time;Brain participation;Modified Ashworth Scale;

Countries

China

Contacts

Public ContactWen Li

The Second Affiliated Hospital of Wannan Medical College

liwenzhiheng@163.com+86 189 5535 3355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026